4-(6,7-Dimethoxy-quinazolin-4-yl)-piperazine-1-carbothioic acid cyclohexylmethyl-amide

ID: ALA341602

PubChem CID: 9804548

Max Phase: Preclinical

Molecular Formula: C23H24ClN7O2

Molecular Weight: 465.95

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2ncnc(N3CCN(/C(=N\Cc4ccc(Cl)cc4)NC#N)CC3)c2cc1OC

Standard InChI:  InChI=1S/C23H24ClN7O2/c1-32-20-11-18-19(12-21(20)33-2)28-15-29-22(18)30-7-9-31(10-8-30)23(27-14-25)26-13-16-3-5-17(24)6-4-16/h3-6,11-12,15H,7-10,13H2,1-2H3,(H,26,27)

Standard InChI Key:  SHSIPFRSMGKGSV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    4.0917   -6.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417   -5.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0875   -2.5292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417   -5.1792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417   -3.6667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0917   -7.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4417   -5.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0875   -1.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042   -6.3042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4417   -7.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0875   -1.1250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7875   -6.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7875   -7.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3917   -2.5292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7542   -7.4500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042   -7.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0917   -4.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4000   -4.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4000   -4.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0917   -4.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0542   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0167   -1.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7042   -2.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -5.9417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -7.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6792   -1.4000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.3625   -1.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0167   -2.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7042   -1.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3667   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4417   -6.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4792   -7.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  6  1  0
  4  3  1  0
  5  2  1  0
  6 20  1  0
  7  1  1  0
  8  1  2  0
  9  4  1  0
 10  2  2  0
 11  7  2  0
 12  9  3  0
 13  8  1  0
 14 13  2  0
 15  3  2  0
 16  7  1  0
 17 16  2  0
 18  5  1  0
 19  5  1  0
 20 19  1  0
 21 18  1  0
 22 15  1  0
 23 29  2  0
 24 22  1  0
 25 13  1  0
 26 14  1  0
 27 23  1  0
 28 30  2  0
 29 31  1  0
 30 24  1  0
 31 24  2  0
 32 25  1  0
 33 26  1  0
 14 11  1  0
 10 17  1  0
 21  6  1  0
 23 28  1  0
M  END

Associated Targets(Human)

PDGFRB Tclin Platelet-derived growth factor receptor (507 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.95Molecular Weight (Monoisotopic): 465.1680AlogP: 3.05#Rotatable Bonds: 5
Polar Surface Area: 98.90Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.33CX LogP: 3.58CX LogD: 3.58
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -1.11

References

1. Matsuno K, Nakajima T, Ichimura M, Giese NA, Yu JC, Lokker NA, Ushiki J, Ide S, Oda S, Nomoto Y..  (2002)  Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.,  45  (20): [PMID:12238930] [10.1021/jm0201114]

Source